Literature DB >> 32479815

COVID-19 and the impact on malaria.

Jane Chiodini1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32479815      PMCID: PMC7258844          DOI: 10.1016/j.tmaid.2020.101758

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN: 1477-8939            Impact factor:   6.211


× No keyword cloud information.
As COVID -19 continues to dominate the health and political agendas in so many countries around the world, so does its devastating impact on other diseases become apparent. Malaria is just one of these. Back in March, the Director of the WHO Global Malaria Programme, Dr Pedro Alonso, stressed the importance of maintaining malaria prevention, diagnostic and treatment activities. Such measures were a key strategy for reducing the strain on health systems when an extra burden is anticipated due to COVID-19. Such systems included continuing with vector control such as insecticide treated nets (ITNs), indoor residual spraying, chemoprevention for pregnant women and young children. On 23rd April, just prior to World Malaria Day (held on 25th April each year), the World Health Organization (WHO) published a report in which a new modelling analysis by the WHO and partners considered ‘nine scenarios for potential disruptions in access to core malaria control tools during the pandemic in 41 countries, and the resulting increases that may be seen in cases and deaths. Under the worst-case scenario, in which all insecticide-treated net campaigns are suspended and there is a 75% reduction in access to effective antimalarial medicines, the estimated tally of malaria deaths in sub-Saharan Africa in 2020 would reach 769 000, twice the number of deaths reported in the region in 2018. This would represent a return to malaria mortality levels last seen in the year 2000’. The document can be found at https://www.who.int/publications-detail/the-potential-impact-of-health-service-disruptions-on-the-burden-of-malaria and a newsroom statement at https://www.who.int/news-room/detail/23-04-2020-who-urges-countries-to-move-quickly-to-save-lives-from-malaria-in-sub-saharan-africa. So the need to continue to fully engage with malaria prevention and treatment measures has never been more vital whilst being mindful of the risks to those undertaking the care. On the 5th May a joint interim guidance document from the WHO, UNICEF and the International Federation of Red Cross (IFRC) was published, entitled Community-based health care, including outreach and campaigns, in the context of the COVID-19 pandemic. This document addresses the role of community-based health care in the pandemic context. It includes practical recommendations for decision makers to help keep communities and health workers safe, to sustain essential services at the community level, and to ensure an effective response to COVID-19. https://www.who.int/publications-detail/community-based-health-care-including-outreach-and-campaigns-in-the-context-of-the-covid-19-pandemic. The WHO has created a webpage which jointly addresses endemic malaria and the pandemic. This page contains the documents already mentioned, but in addition a range of other resources including some social medical cards to help share the strong messages as shown below. Also included is the link to a virtual symposia and the one highlighted is an interview with Dr Pedro Alonso, in which he discussed the challenges of simultaneously fighting the COVID-19 pandemic, and controlling malaria outbreaks in endemic countries, looking at the medical and public health concerns and strategies for addressing the threats successfully. See https://www.who.int/malaria/areas/epidemics_emergencies/covid-19/en/ Whilst international travel is very limited at the current time, one can only imagine if the impact of COVID-19 on the burden on malaria control is significant and risk increases to the situation seen in the year 2000, then the increased threat of malaria infection to travellers will become an unintentional consequence. Time will inform us, but we all have a responsibility to raise awareness of the importance of the potential impact faced and support the practical measures which must continue to happen.
  8 in total

1.  Seroreactivity of the Severe Acute Respiratory Syndrome Coronavirus 2 Recombinant S Protein, Receptor-Binding Domain, and Its Receptor-Binding Motif in COVID-19 Patients and Their Cross-Reactivity With Pre-COVID-19 Samples From Malaria-Endemic Areas.

Authors:  Abdouramane Traoré; Merepen A Guindo; Drissa Konaté; Bourama Traoré; Seidina A Diakité; Salimata Kanté; Assitan Dembélé; Abdourhamane Cissé; Nathan C Incandela; Mamoudou Kodio; Yaya I Coulibaly; Ousmane Faye; Andrey V Kajava; Federico Pratesi; Paola Migliorini; Anna Maria Papini; Lorenzo Pacini; Paolo Rovero; Fosca Errante; Mahamadou Diakité; Myriam Arevalo-Herrera; Socrates Herrera; Giampietro Corradin; Saidou Balam
Journal:  Front Immunol       Date:  2022-04-27       Impact factor: 8.786

2.  Trends of the global, regional and national incidence of malaria in 204 countries from 1990 to 2019 and implications for malaria prevention.

Authors:  Qiao Liu; Wenzhan Jing; Liangyu Kang; Jue Liu; Min Liu
Journal:  J Travel Med       Date:  2021-07-07       Impact factor: 8.490

3.  [Co-infection of malaria and COVID-19 in patients admitted to the COVID Infectious Disease Department of the Libreville University Hospital Center].

Authors:  Marielle Igala; Elsa Ayo Bivigou; Ulrich Davy Kombila; Stéphanie Ntsame Ngoua; Jean Felix Ngomas; Adrien Mougougou; Arsène Ifoudji Makao; Charlene Manomba; Irène Augustine Mistoul; Gabrielle Atsame Ebang; Anita Akiko Mbourou; Metogho Essandone; Liliane Flore Pemba; Annick Flore Mfoumou; Fifi Claire Ada Loembe; Léonard Kouegnigan Rerambiah; Jean Bruno Boguikouma; Marielle Karine Bouyou Akotet
Journal:  Pan Afr Med J       Date:  2022-02-04

4.  Plasmodium vivax in the Elimination Phase - China, 2013-2020.

Authors:  Li Zhang; Boyu Yi; Zhigui Xia; Fang Huang
Journal:  China CDC Wkly       Date:  2022-07-15

5.  SARS-CoV-2 and Plasmodium falciparum Co-Infection in a Returning Traveler.

Authors:  Qian Huang; Wen-Jie Xu; Xiao-Xiao Wang; Xuan Zhang; Ke-Nu Pan; Jia-Qi Zhang; Hua-Liang Chen; Wei Ruan; Li-Nong Yao
Journal:  Front Public Health       Date:  2022-08-05

6.  Implementation and challenges to preventing the re-establishment of malaria in China in the COVID-19 era.

Authors:  Guangyu Lu; Yuanyuan Cao; Dongying Zhang; Yuying Zhang; Yuhui Xu; Yan Lu; Qi Chen; Guoding Zhu; Jun Yan; Olaf Müller; Jun Cao
Journal:  Global Health       Date:  2022-06-21       Impact factor: 10.401

7.  Digitalized long-lasting insecticidal nets mass distribution campaign in the context of Covid-19 pandemic in Kongo Central, Democratic Republic of Congo: challenges and lessons learned.

Authors:  Joris Losimba Likwela; Phillipe Lukanu Ngwala; Albert Kalonji Ntumba; Deogratias Cibinda Ntale; Eric Mukomena Sompwe; Godé Kanyeba Mpiana; Joseph Kalonji Tshula; Tathy Kalonda Likwela; Patrick Kanku-Ka-Munabe; Adrien N 'siala Kumbi; Gilbert Kulimushi Ndahambara; Helen Cibinda Ntale; Michele Luntadila Kiamenga; Jules Kabongo Njila; Ghislain Makhan Yav; Didier Gasigwa Baneti; Julian Austin
Journal:  Malar J       Date:  2022-09-01       Impact factor: 3.469

8.  Transient knockdown of Anopheles stephensi LRIM1 using RNAi increases Plasmodium falciparum sporozoite salivary gland infections.

Authors:  Peter F Billingsley; Kasim I George; Abraham G Eappen; Robert A Harrell; Robert Alford; Tao Li; Sumana Chakravarty; B Kim Lee Sim; Stephen L Hoffman; David A O'Brochta
Journal:  Malar J       Date:  2021-06-26       Impact factor: 2.979

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.